Health
Why Sangamo Therapeutics (SGMO) Could Be Positioned for a Surge
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is a clinical-stage biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the ... [Read]